BACKGROUND: In 2004, an outbreak of the USA300 strain of methicillin-resistant Staphylococcus aureus (MRSA) was identified in persons with histories of homelessness, illicit drug use or incarceration in the Calgary Health Region (Calgary, Alberta). A prevalence study was conducted to test the hypotheses for factors associated with USA300 colonization or infection. METHODS: Participants were recruited at sites accessed by this marginalized population. Health care staff administered a questionnaire and collected crack pipes and nasal, axillary and skin infection swabs. Pipes and swabs were cultured according to standard techniques. MRSA isolates were further characterized by polymerase chain reaction (mecA, Panton-Valentine leukocidin and Staphylococcal cassette chromosome mec) and typing methods (pulsed-field gel electrophoresis, staphylococcal protein A typing and multilocus sequence typing). Colonization or infection was determined by having any one of nasal, axillary, skin infection or pipe swabs positive for USA300. Colonized participants had one or more nasal, axillary or pipe swab positive for USA300; infected participants had one or more skin infection swab positive for USA300. RESULTS: The prevalence of USA300 colonization or infection among 271 participants was 5.5% (range 3.1% to 9.0%). USA300 cases were more likely to report manipulation of skin infections (OR 9.55; 95% CI 2.74 to 33.26); use of crack pipes was not significant despite identification of the USA300 strain on two of four crack pipes tested. USA300 cases were more likely to report drug use between sex trade workers and clients (OR 5.86; 95% CI 1.63 to 21.00), and with casual sex partners (OR 5.40; 95% CI 1.64 to 17.78). CONCLUSION: Ongoing efforts to promote the appropriate treatment of skin infections in this population are warranted. The association of USA300 colonization or infection and drug use with sexual partners suggest a role for sexual transmission of the USA300 strain of MRSA.
BACKGROUND: In 2004, an outbreak of the USA300 strain of methicillin-resistant Staphylococcus aureus (MRSA) was identified in persons with histories of homelessness, illicit drug use or incarceration in the Calgary Health Region (Calgary, Alberta). A prevalence study was conducted to test the hypotheses for factors associated with USA300 colonization or infection. METHODS:Participants were recruited at sites accessed by this marginalized population. Health care staff administered a questionnaire and collected crack pipes and nasal, axillary and skin infection swabs. Pipes and swabs were cultured according to standard techniques. MRSA isolates were further characterized by polymerase chain reaction (mecA, Panton-Valentine leukocidin and Staphylococcal cassette chromosome mec) and typing methods (pulsed-field gel electrophoresis, staphylococcal protein A typing and multilocus sequence typing). Colonization or infection was determined by having any one of nasal, axillary, skin infection or pipe swabs positive for USA300. Colonized participants had one or more nasal, axillary or pipe swab positive for USA300; infected participants had one or more skin infection swab positive for USA300. RESULTS: The prevalence of USA300 colonization or infection among 271 participants was 5.5% (range 3.1% to 9.0%). USA300 cases were more likely to report manipulation of skin infections (OR 9.55; 95% CI 2.74 to 33.26); use of crack pipes was not significant despite identification of the USA300 strain on two of four crack pipes tested. USA300 cases were more likely to report drug use between sex trade workers and clients (OR 5.86; 95% CI 1.63 to 21.00), and with casual sex partners (OR 5.40; 95% CI 1.64 to 17.78). CONCLUSION: Ongoing efforts to promote the appropriate treatment of skin infections in this population are warranted. The association of USA300 colonization or infection and drug use with sexual partners suggest a role for sexual transmission of the USA300 strain of MRSA.
Entities:
Keywords:
Homeless persons; Methicillin resistance; Prevalence; Sexual behaviour; Staphylococcus aureus
Authors: Edwin D Charlebois; Françoise Perdreau-Remington; Barry Kreiswirth; David R Bangsberg; Daniel Ciccarone; Binh A Diep; Valerie L Ng; Kimberly Chansky; Brian R Edlin; Brian Edlin; Henry F Chambers Journal: Clin Infect Dis Date: 2004-06-01 Impact factor: 9.079
Authors: John S Francis; Meg C Doherty; Uri Lopatin; Cecilia P Johnston; Gita Sinha; Tracy Ross; Mian Cai; Nadia N Hansel; Trish Perl; John R Ticehurst; Karen Carroll; David L Thomas; Eric Nuermberger; John G Bartlett Journal: Clin Infect Dis Date: 2004-12-07 Impact factor: 9.079
Authors: Loren G Miller; Francoise Perdreau-Remington; Gunter Rieg; Sheherbano Mehdi; Josh Perlroth; Arnold S Bayer; Angela W Tang; Tieu O Phung; Brad Spellberg Journal: N Engl J Med Date: 2005-04-07 Impact factor: 91.245
Authors: Erica S Pan; Binh An Diep; Edwin D Charlebois; Colette Auerswald; Heather A Carleton; George F Sensabaugh; Françoise Perdreau-Remington Journal: J Infect Dis Date: 2005-08-02 Impact factor: 5.226
Authors: Nolan E Lee; Melanie M Taylor; Elizabeth Bancroft; Peter J Ruane; Margie Morgan; Lucie McCoy; Paul A Simon Journal: Clin Infect Dis Date: 2005-04-13 Impact factor: 9.079
Authors: Sophia V Kazakova; Jeffrey C Hageman; Matthew Matava; Arjun Srinivasan; Larry Phelan; Bernard Garfinkel; Thomas Boo; Sigrid McAllister; Jim Anderson; Bette Jensen; Doug Dodson; David Lonsway; Linda K McDougal; Matthew Arduino; Victoria J Fraser; George Killgore; Fred C Tenover; Sara Cody; Daniel B Jernigan Journal: N Engl J Med Date: 2005-02-03 Impact factor: 91.245
Authors: Blanca E Gonzalez; Gerardo Martinez-Aguilar; Kristina G Hulten; Wendy A Hammerman; Jorge Coss-Bu; Anna Avalos-Mishaan; Edward O Mason; Sheldon L Kaplan Journal: Pediatrics Date: 2005-03 Impact factor: 7.124
Authors: Ana M Avalos Mishaan; Edward O Mason; Gerardo Martinez-Aguilar; Wendy Hammerman; Jennifer J Propst; James R Lupski; Pawel Stankiewicz; Sheldon L Kaplan; Kristina Hulten Journal: Pediatr Infect Dis J Date: 2005-03 Impact factor: 2.129
Authors: Katherine M Campbell; Andrew F Vaughn; Kevin L Russell; Besa Smith; Dinice L Jimenez; Christopher P Barrozo; John R Minarcik; Nancy F Crum; Margaret A K Ryan Journal: J Clin Microbiol Date: 2004-09 Impact factor: 5.948
Authors: Fred C Tenover; Isabella A Tickler; Richard V Goering; Barry N Kreiswirth; José R Mediavilla; David H Persing Journal: Antimicrob Agents Chemother Date: 2011-12-12 Impact factor: 5.191
Authors: Jessica H Leibler; Jane M Liebschutz; Julia Keosaian; Catherine Stewart; Jordanna Monteiro; Alexander Woodruff; Michael D Stein Journal: J Urban Health Date: 2019-10 Impact factor: 3.671
Authors: Cristina Moran Toro; Jack Janvier; Kunyan Zhang; Kevin Fonseca; Dan Gregson; Deirdre Church; Kevin Laupland; Harvey Rabin; Sameer Elsayed; John Conly Journal: Can J Infect Dis Med Microbiol Date: 2014-05 Impact factor: 2.471